Biotech Valuations as Preparation for out-Licensing and Investment

Biotechnology often offers a promise of future success but knowing it can take years and needs proper planning to determine how the effort and expense will translate into returns. In this 45-minute interactive workshop, held in a Zoom breakout room, experts will explore the key considerations around biotech valuations when preparing for out-licencing deals for specific assets, considering a public listing or when raising a next round of financing.

• Why every biotech should create a valuation model
• Common mistakes in valuations and how to avoid them
• Gaining the upper hand in negotiations

Tobias Thornblad, CEO, MS&C Nordics

The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

Subscribe to our channel for more videos.

Follow us on Twitter:   / lsxleaders  

Visit us at www.lsxleaders.com